2024    2023    2022    2021    2020    2019    2018    2017    2016   

2018

Articles

101 - 

Exercise Oximetry and Laser Speckle Contrast Imaging to Assess Microvascular Function in Lower Extremity Peripheral Artery Disease

D Lanéelle, O Stivalet, Guillaume Mahé, V Jaquinandi, L Omarjee et al.

Cardiovascular Drugs and Therapy, 2018, 32 (4), pp.405-407.

DOI : https://doi.org/10.1007/s10557-018-6806-x

Pubmed : 29987479

 

102 - 

Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis comparison between methotrexate and cyclosporine

Sarah Law Ping Man, Guillaume Bouzillé, Nathalie Beneton, Gilles Safa, Alain Dupuy et al.

Journal of the European Academy of Dermatology and Venereology, 2018, 32 (8), pp.1327-1335.

DOI : https://doi.org/10.1111/jdv.14880

Pubmed : 29444359

 

103 - 

Serum hCG threshold to assess medical abortion success

Maela Le Lous, Anne-Claire Gallinand, Bruno Laviolle, Lucas Peltier, Krystel Nyangoh Timoh et al.

European Journal of Contraception and Reproductive Health Care, 2018, 23 (6), pp.458-463.

DOI : https://doi.org/10.1080/13625187.2018.1539162

Pubmed : 30601107

 

104 - 

Induction or escalation therapy for patients with multiple sclerosis?

Emmanuelle Le Page, Gilles Edan

Revue Neurologique, 2018, 174 (6), pp.449-457. ⟨hal-01833126v2⟩

DOI : https://doi.org/10.1016/j.neurol.2018.04.004

Pubmed : 29799415

 

105 - 

I had a dream…

Christophe Leclercq, Vincent Galand, Nathalie Behar, Raphael Martins

European Journal of Heart Failure, 2018, 20 (10), pp.1482-1484.

DOI : https://doi.org/10.1002/ejhf.1243

Pubmed : 29952058

 

106 - 

Propensity score methods The study of the effect of beta-interferon and glatiramer acetate on multiple sclerosis disability

Mathilde Lefort, Gilles Edan, Emmanuelle Leray

Pharmacoepidemiology and Drug Safety, 2018, 27, pp.191-192.

 

107 - 

Outcomes of Perianal Fistulising Crohn's Disease Following Anti-TNF alpha Treatment Discontinuation

Clémence Legué, Charlène Brochard, Gregoire Bessi, Timothée Wallenhorst, Marie Dewitte et al.

Inflammatory Bowel Diseases, 2018, 24 (6), pp.1107-1113.

DOI : https://doi.org/10.1093/ibd/izy008

Pubmed : 29733370

 

108 - 

Safety and Efficacy of 6-thioguanine as a Second-line Treatment for Autoimmune Hepatitis

Clémence Legué, Ludivine Legros, Solène Kammerer-Jacquet, Caroline Jézequel, Pauline Houssel-Debry et al.

Clinical Gastroenterology and Hepatology, 2018, 16 (2), pp.290-291.

DOI : https://doi.org/10.1016/j.cgh.2017.07.032

Pubmed : 28782666

 

109 - 

Suivi thérapeutique pharmacologique du 5-fluorouracile : mise au point et recommandations du groupe STP-PT de la SFPT et du GPCO-Unicancer 5-fluorouracil therapeutic drug monitoring Update and recommendations of the STP-PT group of the SFPT and the GPCO-Unicancer

Florian Lemaitre, Françoise Goirand, Manon Launay, Etienne Chatelut, Jean-Christophe Boyer et al.

Suivi thérapeutique pharmacologique du 5-fluorouracile : mise au point et recommandations du groupe STP-PT de la SFPT et du GPCO-Unicancer. Bulletin du Cancer, 2018, 105 (9), pp.790-803.

DOI : https://doi.org/10.1016/j.bulcan.2018.06.008

Pubmed : 30103904

 

110 - 

Is electroconvulsive therapy an evidence-based treatment for catatonia? A systematic review and meta-analysis

Arnaud Leroy, Florian Naudet, Guillaume Vaiva, Andrew Francis, Pierre Thomas et al.

European Archives of Psychiatry and Clinical Neuroscience, 2018, 268 (7), pp.675-687.

DOI : https://doi.org/10.1007/s00406-017-0819-5

Pubmed : 28639007